UBS Lifts Price Target on Silver Standard (SSRI), Lowers Targets on Silver Wheaton (SLW), Yamana (AUY)
More News related to AUY
- Davenport downgrades Yamana Gold Inc. (AUY) to Buy; Valuation Call
- Gold's Surge Unlikely To Slow As China Could Emerge As Massive Gold Reserve Buyer
- Gold Hit As Dubai Woes Sends Dollar Higher
- Central Banks Continue Snapping Up Gold, Sri Lanka Buys 10 Metric Tons From IMF
- Gold Higher On Reports India Could Buy the Rest of the IMF's Hoard (GLD)
More News related to SLW
- Notable 52-Week High's and Low's: BMY, JCG, PBR, SLW, GOOG, INCY, NTAP, QADI, GOLD, BONT Higher; SPWRB Low
- Silver Wheaton appoints George Brack to its board of directors
- RBC Upgrades Silver Wheaton (SLW) to Outperform
- Alexco Completes Positive Bellekeno Mine Development Plan, Silver Wheaton Concurs-Initiation of Construction Approved
- Canaccord Adams Maintains a 'Buy' on Silver Wheaton (SLW); Raises Price Target
More News related to SSRI
- Silver Standard Resources Inc.-Snowfield and Brucejack Gold Resources: M&I-23.80 Million Ounces, Inferred-14.91 Million Ounces
- Silver Standard Resources Inc.-Snowfield and Brucejack Gold Resources: M&I-23.80 Million Ounces, Inferred-14.91 Million Ounces
- Silver Standard Resources Inc.: Sale of Canadian ABCP Notes
- Silver Standard Resources Inc.: Sale of Canadian ABCP Notes
- A New Way To Play The Rise In Gold: Market Vectors Junior Gold Miners ETF (GDXJ)
More News related to Analyst Comments
- Is Google (GOOG) Worth $1000/Share?
- Wedbush Reiterates an 'Outperform' on Dyax Corp. (DYAX); Lowers Fair Value Estimate
- Piper Jaffray Up Target on Google (GOOG) to $700, Says Long Term It Will Go Over $1000
- IT Will Grow in 2010: Apple and Green-Tech Will Lead the Way (AAPL, RIMM, GOOG, MSFT)
- Microsoft (MSFT) Stock Higher as BofA Analyst Lifts Price Target to $37
UBS adjusted its price targets on several Gold & Silver stocks this morning:
- Silver Wheaton (NYSE: SLW) target moved from $13 to $12.50
- Yamana Gold (NYSE: AUY) target cut from $11.50 to $11
- Silver Standard (Nasdaq: SSRI) target raised from $24.50 to $25
Related Categories
Analyst CommentsStocks Mentioned
-0.52Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
